CLPT Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	124 059
Average Volume	153 406
Market Cap	148.89M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.54
ATR14	$0.0130 (0.24%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-20	Sabra Mazin	Buy	65 252	Restricted Stock Units
2024-05-20	Stigall L. Jeremy	Buy	77 487	Restricted Stock Units
2024-05-20	D'alessandro Danilo	Buy	81 566	Restricted Stock Units
2024-05-20	Burnett Joseph Michael	Buy	212 071	Restricted Stock Units
2024-05-16	Fallon Lynnette C	Buy	21 093	Restricted Stock Units

INSIDER POWER
65.90
Last 96 transactions
Buy: 1 306 302 \| Sell: 225 209

Volume Correlation

Long: -0.02 (neutral)

Short: 0.79 (moderate)

Signal:(70.952) Neutral

Clearpoint Neuro Inc Correlation

10 Most Positive Correlations
OZEM	1
HCAT	0.877
LSXMA	0.82
AUVI	0.818
LUCD	0.818
LSXMK	0.817
EWCZ	0.812
BOTJ	0.81
LIQT	0.808
HAIN	0.807

10 Most Negative Correlations
PWP	-0.824
IGLD	-0.82
BLIN	-0.817
PPTA	-0.816
STAA	-0.815
BRY	-0.814
GALT	-0.809
RZLT	-0.806

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Clearpoint Neuro Inc Correlation - Currency/Commodity

0.56
( weak )

0.57
( weak )

0.00
( neutral )

0.36
( neutral )

-0.58
( weak negative )

Clearpoint Neuro Inc Financials

Annual	2023
Revenue:	$23.96M
Gross Profit:	$13.61M (56.83 %)
EPS:	$-0.900

FY	2023
Revenue:	$23.96M
Gross Profit:	$13.61M (56.83 %)
EPS:	$-0.900

FY	2022
Revenue:	$20.55M
Gross Profit:	$13.53M (65.84 %)
EPS:	$-0.680

FY	2021
Revenue:	$16.30M
Gross Profit:	$11.29M (69.27 %)
EPS:	$-0.690

Financial Reports:

No articles found.

Clearpoint Neuro Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Clearpoint Neuro Inc

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.